CN112725222B - Bacillus subtilis Q3 for producing complex enzyme, culture method and application - Google Patents
Bacillus subtilis Q3 for producing complex enzyme, culture method and application Download PDFInfo
- Publication number
- CN112725222B CN112725222B CN202011520077.3A CN202011520077A CN112725222B CN 112725222 B CN112725222 B CN 112725222B CN 202011520077 A CN202011520077 A CN 202011520077A CN 112725222 B CN112725222 B CN 112725222B
- Authority
- CN
- China
- Prior art keywords
- bacillus subtilis
- culture
- echinacea
- microbial inoculum
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Botany (AREA)
- Food Science & Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a bacillus subtilis for producing complex enzyme, a culture method and application. A Bacillus subtilis Q3 producing complex enzyme is preserved in China center for type culture collection in 2017, 11 months and 17 days, and the strain preservation number is CCTCC NO: m2017701. The bacillus subtilis disclosed by the invention is separated from leaf mold, can produce cellulase and pectinase, and has an inhibiting effect on common pathogenic bacteria. The Bacillus subtilis can be used as animal feed additive. The application of Q3 bacteria for fermenting Echinacea purpurea can improve the release of effective components in Echinacea purpurea, improve the growth promotion, immunity enhancement and disease prevention and treatment effects of Echinacea purpurea. The bacterium and the echinacea fermentation preparation have good market application prospect.
Description
Technical Field
The invention belongs to the technical field of microorganisms and the field of traditional Chinese medicine fermentation, and particularly relates to a bacillus subtilis Q3 for producing complex enzyme, a culture method and application.
Background
The Chinese herbal medicine is a treasure from China, has been used for thousands of years in China, and plays an important role in preventing and treating human diseases. The Chinese herbal medicine contains effective components with the functions of enhancing immunity, resisting bacteria and viruses, promoting growth and the like, and can be used for conditioning, health care and disease prevention and treatment of human and animals. With the increase of work and life pressure of human beings and the acceleration of rhythm, many people are in states of tension, anxiety, dysphoria and irregular life, which causes sub-health, immune metabolism disorder and even illness, and at the moment, the Chinese herbal medicine has the advantages of conditioning, health care and disease prevention. With the limited use of antibiotics in the domestic and foreign breeding industry, the Chinese herbal medicine is used as an antibiotic substitute for preventing and treating livestock and poultry diseases, and has wide application prospect.
The cell walls of the Chinese herbal medicines contain a large amount of cellulose, pectin and other components, which hinder the release of effective components in cells, thereby affecting the use effect of the Chinese herbal medicines. The technology for promoting the wall breaking of the plant cells can improve the separation of the effective components in the Chinese herbal medicine. At present, the technology for breaking the wall of the Chinese herbal medicine comprises superfine grinding, stewing, organic solvent extraction, ultrasonic crushing, enzymolysis, microbial fermentation and the like, wherein the microbial fermentation method is favored because of the advantages of high efficiency, environmental protection and the like. A considerable number of bacteria and fungi exist in nature which secrete enzymes to degrade plant cell walls. Most of microorganisms commonly used for degrading plant cell walls at present are fungi capable of producing cellulase, such as trichoderma, penicillium, and sporotrichum. The plant cell wall contains components such as pectin and the like besides cellulose, and the cell wall breaking effect of the Chinese herbal medicine is not ideal when the microorganism which can only produce cellulase is used. Therefore, the method screens the microorganisms with high-yield complex enzyme, improves the efficiency of degrading the cell walls of the Chinese herbal medicines by the microorganisms, promotes the separation of effective components in the Chinese herbal medicines, can improve the using effect of the Chinese herbal medicines, and is favorable for promoting the modernization of the Chinese herbal medicines and the application of the Chinese herbal medicines in the medical and breeding industries.
Based on the defects of the prior art, microorganisms which produce complex enzyme and have good effect of breaking cell walls of plants need to be separated. The Bacillus subtilis has wide enzyme production spectrum and wide application, can form spores, has strong stress resistance, and is an important microorganism source for screening the wall breaking of Chinese herbal medicines.
Echinacea purpurea is perennial herb of Echinacea of Compositae, contains phenolic acids, polysaccharides, alkylamides, unsaturated ketones, volatile oil, alkaloids, polyacetylenes and other active ingredients, has effects of enhancing immunity, resisting virus, resisting inflammation, resisting oxidation and the like, and can be used for enhancing immunity of human and livestock and preventing and treating diseases. The phenolic acid chicoric acid is the most important effective component in echinacea purpurea and is commonly used for evaluating the quality of echinacea purpurea preparations.
The invention has the following beneficial effects: a bacillus subtilis Q3 with high yield of cellulase and pectinase is separated and identified, and a microbial inoculum is prepared by adopting liquid fermentation culture and solid fermentation culture and is used as an animal feed additive and can promote the growth of animals; the fermented Echinacea preparation prepared by fermenting Echinacea with Q3 bacteria can promote the release of effective components in Echinacea, thereby enhancing the effects of resisting diseases, promoting growth and enhancing immunity of Echinacea.
Disclosure of Invention
Problems to be solved
Aiming at the problem of poor treatment effect of microorganisms for breaking the cell wall of Chinese herbal medicines in the prior art, the invention provides a bacillus subtilis Q3 for producing cellulase and pectinase, and further provides a bacillus subtilis Q3 culture method and a fermented echinacea Chinese herbal medicine preparation prepared by fermenting echinacea by using the bacillus subtilis Q3.
Technical scheme
In order to solve the problems, the technical scheme adopted by the invention is as follows:
the invention provides a bacillus subtilis Q3 for producing complex enzyme, a culture method and application.
The technical scheme of the invention is as follows:
a Bacillus subtilis Q3 producing complex enzyme is preserved in China center for type culture collection in 2017, 11 months and 17 days, and the strain preservation number is CCTCC NO: m2017701.
The Bacillus subtilis Q3 for producing the complex enzyme is characterized by being separated from leaf mold, producing cellulase and pectinase at high yield, and having an inhibiting effect on common pathogenic bacteria such as escherichia coli, salmonella, staphylococcus aureus and the like.
The invention relates to application of Bacillus subtilis Q3 in promoting animal growth, improving immunity and preventing and treating diseases.
The growth-promoting animal feed additive is characterized by comprising an effective dose of Bacillus subtilis Q3 serving as an active ingredient.
The growth-promoting animal feed additive is characterized in that a Q3 microbial inoculum and feed are uniformly mixed according to a certain proportion, so that the number of Q3 microbial inoculum in the feed reaches 1 hundred million CFU/kg.
The growth-promoting animal feed additive is characterized in that the culture method of the bacillus subtilis Q3 comprises the following steps:
(1) Activating strains: inoculating the bacillus subtilis Q3 in a nutrient broth slant culture medium by streak, and placing the culture medium in a constant-temperature incubator at the temperature of 32-35 ℃ for activated culture for 20-24 h;
(2) Preparing a seed solution: selecting activated Q3 bacteria by using an inoculating loop, inoculating the bacteria into a nutrient broth liquid culture medium, and carrying out aerobic shaking culture at the temperature of 32-35 ℃ for 20-24 h, wherein the rotating speed of a shaking table is 150-200 rpm;
(3) Preparing a Q3 liquid microbial inoculum: the spore-forming liquid culture medium is prepared by adding glucose into distilled water per 1000mL 2 5g, 0.5g of yeast extract, 17g of corn steep liquor, 3g of sodium chloride, 0.2g of magnesium sulfate, 5.0g of calcium phosphate, 0.0001g of manganese sulfate, 0.0001g of ferrous sulfate, 7.2 of pH value adjustment, 30min of high-pressure steam sterilization at 121 ℃, inoculating Q3 seed liquid after the temperature of a culture medium is reduced to room temperature, carrying out 5-10% (v/v) of bacterial inoculation amount, carrying out aerobic oscillation culture at 32-35 ℃ for 48-72 h, carrying out 150-210 rpm of shaking table rotation speed, and stopping fermentation when the spore content of Q3 in a fermentation solution is more than or equal to 500 ten thousand CFU/mL, wherein the prepared Q3 bacterial liquid is a Q3 liquid microbial inoculum;
(4) Preparing a Q3 solid microbial inoculum: the formula of the solid fermentation culture medium comprises 10 percent of corn flour, 85 percent of wheat bran, 5 percent of soybean meal, 0.8g of calcium chloride and 0.02g of monopotassium phosphate, the water content is adjusted to be 40-60 percent, the pH value is natural, the mixture is uniformly mixed, the mixture is subpackaged in a high-temperature resistant container, high-pressure steam sterilization is carried out at the temperature of 121 ℃ for 30min, after the temperature of the culture medium is reduced to room temperature, Q3 seed liquid is inoculated, the bacterial inoculation amount is 10-20 percent (v/w), the mixture is uniformly mixed while spraying, the culture medium is placed in a constant-temperature incubator at the temperature of 32-35 ℃ for 3-4 days, the material is turned over once every 12h, the fermented Q3 solid culture is placed in an oven at the temperature of 55 ℃ and dried until the water content is lower than 15 percent, the dried culture is crushed by a crusher, the crushed culture medium is sieved by a 60-mesh sieve, and prepared into powder, and the viable count of Q3 bacteria in the powder is not less than 500 ten thousand CFU/g.
The fermented Chinese herbal medicine for promoting animal growth, improving immunity and preventing diseases is characterized by comprising effective dose of Bacillus subtilis Q3 serving as an active ingredient.
The fermented Chinese herbal medicine for promoting animal growth, improving immunity and preventing diseases is characterized in that the echinacea is fermented by Q3 bacteria.
The fermented Chinese herbal medicine for promoting animal growth, improving immunity and preventing diseases is characterized in that the purple coneflower fermented by the Q3 bacteria and the feed are mixed uniformly according to the proportion of 0.1-0.3% (w/w) and fed.
The fermented Chinese herbal medicine for promoting animal growth, improving immunity and preventing diseases is characterized in that the preparation method of the fermented echinacea preparation comprises the following steps: taking echinacea purpurea powder, adjusting the water content to be 40-60%, subpackaging into a high-temperature resistant container, sterilizing for 30min by high-pressure steam at the temperature of 121 ℃, spraying and inoculating Q3 seed liquid into the sterilized echinacea purpurea powder when the materials are cooled to the room temperature, spraying and inoculating with the bacterial inoculum size of 10-20% (v/w), stirring and uniformly mixing, carrying out solid state fermentation culture at the temperature of 32-35 ℃ for 3-5 days, turning materials once every 12h, after the fermentation is finished, drying the fermented echinacea purpurea in a drying oven at the temperature of 55 ℃ until the water content is lower than 15%, preparing fermented echinacea purpurea powder, subpackaging and storing at the room temperature.
Advantageous effects
The invention discloses a bacillus subtilis Q3 for highly producing cellulase and pectinase, which can degrade cellulose and pectin in plant cell walls and improve the release of effective components in plant cells, thereby improving the bioavailability of plant resources and being used as an animal feed additive. The invention also discloses a liquid fermentation culture method and a solid fermentation culture method of the bacillus subtilis Q3, and the prepared liquid microbial inoculum and solid microbial inoculum with high bacterial count content are used as animal feed additives, can promote the growth of animals and improve the feed conversion rate. The invention also discloses the echinacea purpurea fermented by the bacillus subtilis Q3, and the echinacea purpurea powder can improve the separation of active ingredients such as chicoric acid and the like in the echinacea purpurea after being fermented by the Q3 bacteria, and obviously improve the effects of promoting the growth of animals, improving the immunity, resisting diseases and the like of the echinacea purpurea.
Drawings
FIG. 1A transparent circle of Bacillus subtilis Q3 on a CMC-Congo red agar plate.
FIG. 2 colony morphology of Bacillus subtilis Q3 on nutrient broth agar plates.
Detailed Description
The technical solution of the present invention is further described below with reference to specific examples, but the scope of the present invention includes but is not limited thereto.
The Bacillus subtilis Q3 described in the examples is stored in the China center for type culture Collection in 2017, 11 months and 17 days, and the strain preservation number is CCTCC NO: m2017701.
Example 1: screening and identification of cellulase-producing bacillus subtilis
Weighing 2.0g of leaf mold, placing in a sterilized conical flask, adding appropriate amount of sterilized normal saline, soaking for 3h, centrifuging at low speed, and collecting supernatant. Diluting the supernatant with sterilized normal saline at a ratio of 10 times, and selecting sample solution (such as 10 times of the diluted sample solution) -4 、10 -5 、10 -6 ) Each of the plates was plated on Congo red agar plates containing 1% sodium carboxymethylcellulose, and 100. Mu.l of each sample solution was inoculated. The culture was incubated at 35 ℃ for 72 hours under aerobic conditions, and it was observed whether a transparent circle was formed around the colony. Picking single colony capable of generating transparent ring on cellulose-congo red agar plate, inoculating nutrient broth, and culturing at 35 deg.C under aerobic condition for 24 hr to obtain pure culture of isolated bacteria. The result of the bacteria separation test shows that the transparent circle generated by the strain with the number Q3 is the largest, which indicates that the strain produces cellulase and has high enzyme activity. And (3) smearing a bacterial liquid smear of the Q3 bacterium, and observing under an optical microscope to find that the bacterium is the purple bacillus, which indicates that the bacterium is a gram-positive bacterium. The Q3 strain is dipped by an inoculating loop, streaked and cultured on a nutrient broth solid plate, and aerobically and isothermally cultured at 35 ℃ for 24 hours, wherein the colony is large, round, rough in surface and white.
Genomic DNA of Q3 bacteria was extracted using a bacterial genomic DNA extraction kit according to the instructions. PCR amplification was performed using 16S rDNA universal PCR amplification primers 27F and 1492R. The PCR amplification system was 25. Mu.L, containing 2. Mu.L of bacterial DNA, 2.5. Mu.L of 10 XPCR buffer (containing Mg) 2+ ) dNTPs of 2 mu L, upstream and downstream primers of 0.5 mu L and Taq DNA polymerase of 0.5 mu L respectively, and distilled water is added to 25 mu L. The PCR amplification conditions were: pre-denaturation at 94 ℃ for 5min, denaturation at 94 ℃ for 30s, renaturation at 57 ℃ for 30s, extension at 72 ℃ for 1min for 30 cycles, and the mostAnd then extended at 72 ℃ for 5min. The PCR amplification product was sent to a sequencing company for gene sequencing. The gene sequence is uploaded to a Genbank database, and the accession number of the gene sequence is MW334967. Logging in NCBI website, inputting gene sequence into BLAST online analysis platform, and performing sequence comparison analysis. The result of 16S rDNA sequence comparison analysis shows that the Q3 bacterium is bacillus subtilis.
Example 2: enzymatic characteristic analysis of cellulase and pectinase produced by bacillus subtilis Q3
Preparing a bacillus subtilis Q3 crude enzyme solution: preparing nutrient broth culture medium, sterilizing with high pressure steam at 121 deg.C for 30min, cooling the culture medium to room temperature, adding Q3 seed solution at 6% (v/v) inoculum size, placing in shaking table, culturing under aerobic shaking at 35 deg.C for 72h, and rotating the shaking table at 180rpm. Centrifuging the bacterial liquid at 10000rpm for 10min, and obtaining the supernatant as the crude enzyme liquid. And respectively measuring the enzyme activities of the cellulase and the pectinase in the crude enzyme solution.
(1) Analysis of enzyme activity of cellulase in crude enzyme solution of Bacillus subtilis Q3
The filter paper enzyme activity represents the total enzyme activity after the synergistic action of three enzyme components of the cellulase. The enzyme activity of the cellulase is determined by a filter paper method. The method is carried out according to the specification of a filter paper method for measuring the activity of the feeding cellulase of GB/T23881-2009.
1g of glucose was weighed and dissolved in 100mL of 0.05mol/L citrate buffer, pH 5.7, to prepare a 10mg/mL glucose standard solution. Taking 7 test tubes with 25mL scales with plugs, accurately sucking 0, 0.04, 0.06, 0.08, 0.12, 0.16 and 0.2mL of glucose solution into each test tube respectively, adding distilled water to 2.0mL respectively, adding 2mL of DNS reagent into each test tube respectively, carrying out boiling water bath for 5 minutes, taking out, cooling to room temperature immediately by using cold water, adding distilled water to a constant volume of 25mL, shaking up, and measuring the OD value at a wavelength of 540 nm. As absorbance OD 540 Values are plotted on the abscissa and glucose standard curves are plotted on the ordinate versus the number of milligrams of sugar in the glucose standard solution.
50mg of a shredded filter paper strip was added to a 25mL graduated tube, 0.05mol/L citrate buffer lmL with a pH of 5.7 was added, and the mixture was equilibrated in a 37 ℃ water bath for 10min. Then 0.5mL of properly diluted enzyme solution and 5mL of water are sequentially added, the temperature is kept in a water bath at 37 ℃ for 1 hour, 2mL of DNS reagent is added, the mixture is boiled in the water bath for 5 minutes, the mixture is taken out and immediately cooled to the room temperature by cold water, distilled water is added to the mixture to be constant volume to 25mL, the mixture is shaken up, and the absorbance is measured at 540 nm. Meanwhile, the inactivated enzyme solution after boiling at 100 ℃ for l0min is used as a contrast, and the background is subtracted. Finding out the corresponding glucose content from the glucose standard curve according to the absorbance, and calculating the enzyme activity value according to the gram number of the generated glucose. The filter paper enzyme activity calculation formula is as follows: x = (M × n × 1000)/(t × M). X is the enzyme activity of the filter paper enzyme, and the unit is U/g. And m is the content of glucose found from a glucose standard curve. n is total dilution multiple of enzyme solution. t is the reaction time in min. M is the molar mass of glucose, 180.2g/moL.
The determination result shows that the cellulase activity in the crude enzyme solution of the bacillus subtilis Q3 is 662U/g.
(2) Analysis of the enzyme Activity of the Bacillus subtilis Q3 crude enzyme solution pectinase
And (4) carrying out enzyme activity determination on the pectinase according to a method of an industrial standard QB/T4482-2013. Adding 0.2% polygalacturonic acid substrate 2mL into a test tube with a plug scale, preheating for 5min at 45 ℃, adding 20uL enzyme solution, uniformly mixing, carrying out water bath at 45 ℃ for 15min, sequentially adding 0.03moL of phosphoric acid reagent 3mL, and measuring the OD value at 235 nm. Meanwhile, the inactivated enzyme solution after boiling at 100 ℃ for l0min is used as a contrast, and the background is subtracted. The enzyme activity calculation formula of the pectinase is as follows: x = (a × N × V1 × 1000000)/(t × b × V2 × 1000 × 4600). X is the enzyme activity of pectinase, and the unit is U/g. A is the absorbance of the diluted enzyme solution. N is the dilution factor of the enzyme solution. t is the reaction time in min. b is the thickness of the cuvette in cm. V1 is the total volume of the reaction system in mL. V2 is the volume of the diluted enzyme solution in mL.
The enzyme activity of the pectinase in the crude enzyme solution of the bacillus subtilis Q3 is 279U/g by calculation.
Example 3: research on antibacterial effect of bacillus subtilis Q3
The inhibition effect of the bacillus subtilis on common pathogenic bacteria is measured by an Oxford cup method. Selecting a single bacterial colony of the bacillus subtilis Q3, inoculating the single bacterial colony to a nutrient broth culture medium, carrying out shaking culture at 35 ℃ for 24h, centrifuging the bacterial liquid at 10000rpm for 10min, and taking a supernatant. Picking out single colonies of Escherichia coli ATCC25922, salmonella CMCC50956 and staphylococcus aureus ATCC25923 respectively, inoculating the single colonies into a nutrient broth culture medium, and carrying out shake culture at 37 ℃ for 24h. Respectively sucking 0.1mL of bacterial liquid of various pathogenic bacteria, uniformly coating on a nutrient broth solid plate, placing a sterilized Oxford cup (with the outer diameter of 8 mm) on the solid plate by using an aseptic forceps, and lightly pressing to make the bottom of the cup tightly attached to the solid plate. 0.15mL of Bacillus subtilis Q3 supernatant was added to each Oxford cup. Then placing the culture dish at the constant temperature of 37 ℃ for culturing for 24h, and measuring the diameter of the inhibition zone.
The results of bacteriostatic tests show that the diameters of bacteriostatic rings of the liquid supernatant of the bacillus subtilis Q3 on escherichia coli, salmonella and staphylococcus aureus are 12 mm, 13 mm and 11.6mm respectively, and that the Q3 has an inhibitory effect on common pathogenic bacteria.
Example 4: culture of bacillus subtilis Q3 and preparation of microbial inoculum thereof
Activating strains: and (3) picking a single bacillus subtilis Q3 colony by using an inoculating loop, streaking and inoculating the single bacillus subtilis colony to a nutrient broth slant culture medium, and putting the culture medium in a constant-temperature incubator at 35 ℃ for activation culture for 20 hours.
Preparing a seed solution: a loop of activated Q3 bacteria is picked up by using an inoculating loop, inoculated into 100mL of nutrient broth liquid culture medium, and subjected to shaking culture at 35 ℃ for 24h, and the rotating speed of a shaking table is 180rpm.
(1) Liquid state fermentation culture and liquid microbial inoculum preparation
The formula of the spore-forming liquid culture medium is that 25g of glucose, 0.5g of yeast extract, 17g of corn steep liquor, 3g of sodium chloride, 0.2g of magnesium sulfate, 5.0g of calcium phosphate, 0.0001g of manganese sulfate and 0.0001g of ferrous sulfate are added into each 1000mL of distilled water, and the pH value is adjusted to be 7.2. Sterilizing with high pressure steam at 121 deg.C for 30min.
After the temperature of the liquid culture medium is reduced to room temperature, inoculating Q3 seed liquid according to the inoculation amount of 10% (v/v), carrying out aerobic shaking culture at 35 ℃ for 60h, and rotating the shaking table at 180rpm.
The Q3 bacterial liquid prepared by the method is the spore bacterial agent. The number of spores was checked by plate dilution coating. And (3) carrying out water bath at 80 ℃ for 15min, and detecting the spore content by using a plate dilution method, wherein the number of spores reaches 800 ten thousand CFU/mL.
And (3) storage: and (4) refrigerating the Q3 bacterial liquid in a refrigerator at 4 ℃ or storing the bacterial liquid in a cool place at room temperature.
(2) Solid fermentation culture and preparation of powdered microbial inoculum
Preparing a solid fermentation culture medium: the method comprises the steps of adjusting the water content to 50% according to 10% of corn flour, 85% of wheat bran, 5% of soybean meal, 0.8g of calcium chloride and 0.02g of monopotassium phosphate, naturally adjusting the pH value, uniformly mixing, preparing a solid fermentation culture medium, subpackaging the solid fermentation culture medium in a high-temperature resistant plastic box, sterilizing for 30min by high-pressure steam at 121 ℃, and cooling to room temperature.
Solid fermentation culture: and uniformly spraying the Q3 seed solution into a solid fermentation culture medium according to the inoculation amount of 20%, uniformly mixing, and culturing in a constant-temperature incubator at 35 ℃ for 3 days, wherein the material is turned once every 12 hours.
Drying and crushing: drying the fermented Q3 solid culture in a 55 ℃ oven until the water content is lower than 15%, pulverizing the dried culture with a pulverizer, sieving with a 60-mesh sieve to obtain a powdery microbial inoculum, subpackaging in sealed plastic bags, and storing in dry and cool places.
The viable count of Q3 bacteria in the powder was determined by a plate dilution coating method. The bacteria counting result shows that the viable count of Q3 in the powder reaches 620 ten thousand CFU/g.
Example 5: application effect observation of broiler chicken fed by bacillus subtilis Q3 microbial inoculum
100 broiler chicks of 1 day old are selected and averagely divided into 2 groups, and the average body weight of the two groups is close to that of the two groups. In the treatment group, 20mL of bacillus subtilis Q3 bacterial liquid is added into each kilogram of complete feed, so that the number of spores in the feed is 1.6 hundred million CFU/kg. The control group was fed with commercial complete feed. The two groups of test chickens were fed under the same conditions except for the difference in the feed. The breeding period is 42 days, the ground is adopted for flat breeding, drinking water and food are freely taken, and the illumination is 24 hours. The temperature in the chicken house was 33 ℃ initially tested and subsequently decreased by 1 ℃ every three days until it reached 26 ℃. The vaccine immunization is carried out according to the conventional immunization program. The number of the test chickens, the total weight and the average weight of the test chickens in each group are recorded at the beginning of the test, the number of dead chickens and the feed intake are recorded every day, the test is performed for 12 hours without water prohibition after the test is finished, the weight of each group of chickens is weighed, and the death rate, the average weight gain and the feed-meat ratio of the chickens in each group during the test are calculated. Slaughtering test chickens, collecting cecal contents, extracting genome DNA of cecal microorganisms by using a fecal genome extraction kit, performing metagenome sequencing, and analyzing the diversity of intestinal flora of the test chickens. The results are shown in Table 1.
TABLE 1 influence of Bacillus subtilis Q3 microbial inoculum on growth performance of broiler chickens fed with the bacteria
The test result of the influence of the bacillus subtilis Q3 microbial inoculum on the growth performance of the broiler chicken shows that the death and culling rates of a Q3 microbial inoculum feeding group and a control group are respectively 4% and 6%, the average daily gain is respectively 55.5 g/chicken and 49.1 g/chicken, and the feed-meat ratio is respectively 1.86 and 2.06. The result of a contrast feeding test shows that the Q3 microbial inoculum is safe to chickens and has the effects of promoting growth and resisting diseases.
The sequencing result of the caecum microorganism metagenome shows that the number of lactobacillus, corynebacterium and enterococcus in the caecum of the chicken can be increased to different degrees by feeding the Q3 microbial inoculum, wherein the number of the lactobacillus and the enterococcus is obviously increased (P is less than 0.05); and the number of bacteroides, streptococcus and escherichia coli is reduced, wherein the number of bacteroides and escherichia coli is obviously reduced (P < 0.05).
Example 6: bacillus subtilis Q3 fermented echinacea and application effect observation thereof
Removing impurities from Echinacea purpurea flower floc and rhizome, drying, pulverizing, and sieving with 60 mesh sieve to obtain Echinacea purpurea powder. Uniformly spraying tap water into echinacea purpurea powder, adjusting the water content to be 50%, subpackaging into high-temperature-resistant plastic baskets, sterilizing for 30min by high-pressure steam at 121 ℃, cooling the materials to room temperature, measuring bacillus subtilis Q3 seed solution according to a proportion of 15% (v/w), spraying and inoculating into the sterilized echinacea purpurea powder, spraying while stirring, uniformly mixing, performing solid state fermentation culture at 35 ℃ for 4 days, and turning the materials once every 12 h. After fermentation, placing the fermented Echinacea purpurea in a 55 ℃ oven to dry until the water content is lower than 15%, preparing into fermented Echinacea purpurea powder, subpackaging, and storing at room temperature.
Taking fermented echinacea powder and unfermented echinacea powder with the same mass, and mixing the fermented echinacea powder and the unfermented echinacea powder according to a material-water ratio of 1:10 (w/v) adding distilled water, soaking in refrigerator at 4 deg.C overnight, centrifuging at 10000rpm for 10min, filtering the supernatant with 0.45 μm filter membrane to obtain sample to be testedIt is prepared by pulverizing the above materials. RP-HPLC method is used for analyzing the content of chicoric acid in echinacea purpurea, and standard curve method is used for calculating the content of chicoric acid in fermentation liquor. The high-pressure liquid chromatograph is of Shimadzu LC-20A type, the ultraviolet detector is of SPD-20A type, the detection wavelength is 330nm, and the reversed-phase chromatographic column is Venusil TM XBP C18 column (250 mm × 4.6mm,5 μm), column temperature 35 ℃, sample volume 10 μ L, flow rate 1mL/min, mobile phase acetonitrile: 0.2% phosphoric acid aqueous solution (28. The analysis result shows that the yield of the chicoric acid in the fermented echinacea is 76.2 percent, the yield of the chicoric acid in the unfermented echinacea is 43.8 percent, and the difference of the two is obvious (P is less than 0.05) through the biological statistical analysis. Experimental results prove that the Q3 bacteria fermented echinacea purpurea can promote the separation of the effective component chicoric acid.
300 chicks of 1 day old are averagely divided into 3 groups, each group comprises 100 chickens, the weight of each group of chickens is equivalent, one group of chickens are fed with the feed added with the fermented echinacea, the other group of chickens are fed with the feed added with the unfermented echinacea, and the blank control group of chickens are fed with the common commercial complete feed. The fermented Echinacea feed and the unfermented Echinacea feed are added into the complete feed according to the proportion of 0.3% (w/w) respectively. The three groups of test chickens were fed under the same conditions except for the different feeds. The breeding period is 42 days, the ground is used for flat breeding, drinking water and food are freely taken, and the illumination is 24 hours. The temperature in the chicken house was 33 ℃ initially tested and subsequently decreased by 1 ℃ every three days until it reached 26 ℃. The vaccine immunization is carried out according to the conventional immunization program. The number of the test chickens, the total weight and the average weight of the test chickens in each group are recorded at the beginning of the test, the number of dead chickens and the feed intake are recorded every day, the test is performed for 12 hours without water prohibition after the test is finished, the weight of each group of chickens is weighed, and the death and culling rate, the average weight gain and the feed-meat ratio of the chickens in each group during the test are calculated. At the end of the test, slaughtering the test chickens, picking spleens, weighing and counting the spleen body weight index of each group of chickens.
The results of the feeding test of fermented Echinacea are shown in Table 2. The mortality and washout rates of the fermented echinacea feeding group, the unfermented echinacea feeding group and the blank control group are respectively 2%, 4% and 6%, the average daily gain is respectively 63.1, 56.4 and 49.2 g/mouse, the feed-meat ratio is respectively 1.72, 1.83 and 2.06, and the spleen body weight index is respectively 196.1, 178.8 and 169.3mg/kg. The results of contrast feeding tests show that the echinacea purpurea has the effects of promoting the growth of animals, enhancing the immunity and resisting diseases, and the growth promotion, the immunity enhancement and the disease resistance of the fermented echinacea purpurea are superior to those of the unfermented echinacea purpurea.
TABLE 2 Bacillus subtilis Q3 fermentation Echinacea purpurea feeding broiler chicken test results
Claims (5)
1. Bacillus subtilis (B) for producing complex enzymeBacillus subtilis) Q3, wherein the Bacillus subtilis Q3 is stored in the China center for type culture Collection in 2017, 11.17.s.a., in Wuhan university No. 299 in Wuhan district, wuhan City, hubei province, with the strain preservation number CCTCC NO: m2017701.
2. A growth-promoting animal feed additive comprising, as an active ingredient, an effective amount of bacillus subtilis Q3 according to claim 1.
3. The method for preparing the liquid or solid microbial inoculum of the bacillus subtilis Q3 for producing the compound enzyme according to claim 1, which is characterized by comprising the following steps:
(1) Activating strains: streaking and inoculating the bacillus subtilis Q3 for producing the complex enzyme according to the claim 1 into a nutrient broth slant culture medium, and putting the culture medium in a constant-temperature incubator at 32-35 ℃ for activation culture for 20-24 h;
(2) Preparing a seed solution: selecting activated bacteria by using an inoculating loop, inoculating the activated bacteria into a nutrient broth liquid culture medium, carrying out shake culture at the temperature of 32-35 ℃ for 20-24h, and obtaining seed liquid at the rotating speed of a shaking table of 150-200 rpm;
(3) Preparation of a microbial inoculum:
preparing a liquid microbial inoculum: the formula of the spore-producing liquid culture medium is that 25g of glucose, 0.5g of yeast extract, 17g of corn steep liquor, 3g of sodium chloride, 0.2g of magnesium sulfate, 5.0g of calcium phosphate, 0.0001g of manganese sulfate, 0.0001g of ferrous sulfate, 7.2 of pH value adjustment, 30min of high-pressure steam sterilization at 121 ℃, after the temperature of the culture medium is reduced to room temperature, the seed solution prepared in the step (2) is inoculated, the bacterial inoculum size is 5-10% v/v, aerobic oscillation culture is carried out at 32-35 ℃ for 48-72 h, the rotating speed of a shaking table is 150-200 rpm, fermentation is stopped when the spore content in the fermentation solution is more than or equal to 500 ten thousand CFU/mL, and the prepared bacterial liquid is a liquid microbial inoculum;
or preparing a solid microbial inoculum: the formula of the solid fermentation culture medium comprises 10 percent of corn flour, 85 percent of wheat bran, 5 percent of soybean meal, 0.8g of calcium chloride and 0.02g of monopotassium phosphate, the water content is adjusted to be 40-60 percent, the pH is natural, the mixture is uniformly mixed and is subpackaged in a high-temperature resistant container, the sterilization is carried out for 30min by high-pressure steam at 121 ℃, after the temperature of the culture medium is reduced to room temperature, the seed solution prepared in the step (2) is inoculated, the bacterial inoculation amount is 10-20 percent v/w, the mixture is uniformly mixed while spraying, the culture medium is placed in a constant-temperature incubator at 32-35 ℃ for 3-4 days, the material is turned over once every 12h, the fermented solid culture is placed in an oven at 55 ℃ and dried until the water content is lower than 15 percent, the dried culture is crushed by a crusher and sieved by a sieve of 60 meshes to prepare a powdery microbial inoculum, and the number of viable bacteria in the microbial inoculum is not less than 500 ten thousand CFU/g.
4. A fermented Echinacea purpurea for promoting animal growth, enhancing immunity, and preventing diseases, wherein the fermented Echinacea purpurea is prepared by fermenting Echinacea purpurea using the Bacillus subtilis Q3 producing complex enzyme according to claim 1.
5. The fermented echinacea according to claim 4, wherein the preparation method of the fermented echinacea is: taking echinacea purpurea powder, adjusting the water content to be 40-60%, subpackaging the echinacea purpurea powder in a high-temperature resistant container, sterilizing the echinacea purpurea powder for 30min at 121 ℃ by high-pressure steam, cooling the material to room temperature, inoculating the liquid microbial inoculum prepared by the method according to claim 3, wherein the inoculation amount is 10-20% v/w, spraying and inoculating the liquid microbial inoculum while uniformly mixing, performing solid state fermentation culture at 32-35 ℃ for 3-5 days, turning the material once every 12h, and after the fermentation is finished, drying the fermented echinacea purpurea in a 55 ℃ oven until the water content is lower than 15% to prepare powder.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011520077.3A CN112725222B (en) | 2020-12-21 | 2020-12-21 | Bacillus subtilis Q3 for producing complex enzyme, culture method and application |
ZA2021/02965A ZA202102965B (en) | 2020-12-21 | 2021-05-03 | Enzyme complex-producing bacillus subtilis (b. subtilis) strain q3, and cultivation method and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011520077.3A CN112725222B (en) | 2020-12-21 | 2020-12-21 | Bacillus subtilis Q3 for producing complex enzyme, culture method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112725222A CN112725222A (en) | 2021-04-30 |
CN112725222B true CN112725222B (en) | 2023-01-31 |
Family
ID=75603994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011520077.3A Active CN112725222B (en) | 2020-12-21 | 2020-12-21 | Bacillus subtilis Q3 for producing complex enzyme, culture method and application |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112725222B (en) |
ZA (1) | ZA202102965B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103981118A (en) * | 2013-12-24 | 2014-08-13 | 北京伟嘉人生物技术有限公司 | Bacillus subtilis feed additive and preparation method and application thereof |
CN111690568A (en) * | 2020-07-10 | 2020-09-22 | 中国农业科学院饲料研究所 | Bacillus subtilis and application thereof in fermentation treatment of detoxication of flaxseed cake |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2879511T3 (en) * | 2012-08-03 | 2022-11-14 | Dupont Nutrition Biosci Aps | Feed additive composition |
-
2020
- 2020-12-21 CN CN202011520077.3A patent/CN112725222B/en active Active
-
2021
- 2021-05-03 ZA ZA2021/02965A patent/ZA202102965B/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103981118A (en) * | 2013-12-24 | 2014-08-13 | 北京伟嘉人生物技术有限公司 | Bacillus subtilis feed additive and preparation method and application thereof |
CN111690568A (en) * | 2020-07-10 | 2020-09-22 | 中国农业科学院饲料研究所 | Bacillus subtilis and application thereof in fermentation treatment of detoxication of flaxseed cake |
Non-Patent Citations (1)
Title |
---|
微生物产生的酶抑制剂研究1.蛋白酶抑制剂的筛选方法探讨;刘华珍等;《抗生素》;19831231;第8卷(第5期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
ZA202102965B (en) | 2022-08-31 |
CN112725222A (en) | 2021-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111471624A (en) | Bacillus belgii CSQXDZ26 strain and application thereof | |
CN112358999B (en) | Lactobacillus reuteri and application thereof | |
CN106260540B (en) | Biological feed for creep feed and creep feed | |
CN101691540B (en) | Muscodor endophytic fungi ZJLQ070 and application thereof and fungicide | |
CN102250814B (en) | Bacillus subtilis and use thereof in bio-control preparation for preventing and controlling powdery mildew | |
CN105132312A (en) | Bacillus subtilis and application thereof as well as microbial fungicide containing bacillus subtilis and preparation method of microbial fungicide | |
CN109679882A (en) | One Enterococcus faecalis DT1-1 and its application | |
CN111534459B (en) | Lactobacillus fermentum for high yield of amylase and application of lactobacillus fermentum in preparation of fermented feed | |
CN110791460B (en) | Strain for inhibiting growth of aspergillus flavus and generation of toxin | |
CN100406552C (en) | Pantoea agglomerans and fermentation culture method and application thereof | |
CN110004095A (en) | A kind of preparation method and application of bacillus pumilus antibacterial substance | |
CN114276967A (en) | Lactobacillus plantarum HL-16 and application thereof | |
CN107502565B (en) | One plant of fritillary bulb rhizosphere Paenibacillus polymyxa and its application | |
CN102168053B (en) | Paenibacilluspolymyxa strain for coproduction of LI-F type antibiotic and dibutyl phthalate and application thereof | |
CN107779422B (en) | Non-decarboxylation lecanium biocontrol strain for efficiently inhibiting aspergillus flavus from synthesizing aflatoxin | |
KR102053735B1 (en) | Black ginseng lactic acid bacteria fermentation composition and method for producing the same | |
CN107974424A (en) | Space lactobacillus reuteri Fullarton-9-25 and application | |
CN107937316A (en) | Space lactobacillus reuteri Fullarton 9 71 and application | |
CN111849830A (en) | Bacillus subtilis, preparation and application thereof | |
JP2019517810A (en) | Bacillus licheniformis NY1505 strain producing a large amount of α-glucosidase inhibitor | |
CN101691542A (en) | Muscodor endophytic fungi and application thereof and fungicide | |
CN112725222B (en) | Bacillus subtilis Q3 for producing complex enzyme, culture method and application | |
CN108570422A (en) | One plant of lactobacillus buchneri bacterial strain and its ensilage fermentation agent | |
CN116536207A (en) | Bacillus atrophaeus WLKYSY-4, biological microbial inoculum and application thereof | |
CN115637240A (en) | Bacillus belgii and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |